Tuesday 17 November 2026
Export BRVE’s income statement to Excel — free account
Braveheart Bio, Inc.
BRVE- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
19.38
0.24
−1.22%
Follow BRVE
Alert me
Where the cash went Fiscal 2025, year to 31 December 2025
Free cash flow was −$2.0M: capital expenditures were more than operating cash flow. Cash rose by $89.2M. Lines the picture does not name came to −$33.6M. What is a cash flow statement?
- Free cash flow
- −$2.0M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- +$89.2M over the period
| Operating cash flow | 0.0 |
|---|---|
| Free cash flow | 0.0 |
| Shares issued, net | +0.1 |
| Other | 0.0 |
| Change in cash | 0.1 |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | |
|---|---|
Net Income |
(66.05) |
Non Cash Items (Other) |
62.42 |
Accounts Payable Change |
0.90 |
Change in payables and accrued liability |
0.91 |
Change in other assets and liabilities |
(0.19) |
Operating Cash Flow |
(2.01) |
Other investing activities |
(33.57) |
Investing cash flow |
(33.57) |
Equity Repurchase (Common, Net) |
0.10 |
Equity Repurchase (Preffered, Net) |
124.65 |
Financing cash flow |
124.74 |
Change in Cash |
89.16 |
Ending Cash |
89.16 |
Stock Based Compensation |
0.18 |
Dividends Paid (Common) |
0.00 |
Assets Liabilities Change (Total) |
1.62 |
Issuance/Purchase of Shares |
124.74 |
| Other line items | |
Revenue per Employee |
0.00 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 12 Nov 2026